1. Moe OW, Pearle MS, Sakhaee K: Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int. 2011, 79 ((4): 385-392.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC: Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003, 63 (5): 1817-1823. 10.1046/j.1523-1755.2003.00917.x.
3. Swiss Federal Statistical Office: Scenarios for Population Growth in Switzerland, 2005–2050 (Accessed Nov. 2011.
http://www.bfs.admin.ch/bfs/portal/de/index/themen/01/22/publ.html?publicationID=2411
,
4. Scales CD, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, Preminger GM: Changing gender prevalence of stone disease. In: J Urol. vol. 2007, 177: 979-982.
5. Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR: The association of increasing body mass index and kidney stone disease. In: J Urol. vol. 2010, 183: 571-575.